Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Northann Corp. Common Stock (NY:NCL)

0.6380 -0.0564 (-8.12%)
Official Closing Price Updated: 8:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Northann Corp. Common Stock

< Previous 1 2 3 4 5 Next >
Printing The Future: Northann And I4F Forge Cross-License Deal
Northann strikes a strategic cross-licensing pact with I4F, focusing on digital printing solutions for home improvement. After this cross-license agreement, Northann will manufacture its 3D printing... 
Via Benzinga
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start Tuesday with a breakdown of the biggest pre-market stock movers that investors will want to keep an eye on today! 
Via InvestorPlace
12 Industrials Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Industrials Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million... 
Via Benzinga
12 Industrials Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Friday's Intraday Session
 
Via Benzinga
12 Industrials Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
12 Industrials Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Industrials Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Industrials Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
12 Industrials Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results. 
Via Benzinga
Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
Shares of Aclarion, Inc. (NASDAQ: ACON) shares rose sharply in pre-market trading after the company was granted U.S. patent #11844601 for "MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL... 
Via Benzinga
Topics Intellectual Property
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Industrials Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic... 
Via Benzinga
Why Arcutis Biotherapeutics Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.